Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Oragenics Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −1 vs. Q4 2023
- Shares held
- 186.8K
- +124.7K (+200.9%) vs. Q4 2023
- Total value
- $269.2K
- −$80.3K (−23.0%) vs. Q4 2023
- New holders
- 3
- 6 more added
- Sold out
- 4
- 2 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $39.2K |
| Q1 2026 | 20 | $105.8K |
| Q4 2025 | 19 | $169.3K |
| Q3 2025 | 16 | $160.5K |
| Q2 2025 | 18 | $401.6K |
| Q1 2025 | 22 | $57.2K |
| Q4 2024 | 24 | $86.0K |
| Q3 2024 | 16 | $62.2K |
| Q2 2024 | 16 | $135.6K |
| Q1 2024 | 14 | $269.2K |
| Q4 2023 | 15 | $349.5K |
| Q3 2023 | 13 | $182.1K |
| Q2 2023 | 13 | $173.5K |
| Q1 2023 | 14 | $192.4K |
| Q4 2022 | 31 | $1.08M |
| Q3 2022 | 29 | $2.48M |
| Q2 2022 | 29 | $3.06M |
| Q1 2022 | 28 | $3.62M |
| Q4 2021 | 33 | $4.96M |
| Q3 2021 | 29 | $6.82M |
| Q2 2021 | 22 | $6.63M |
| Q1 2021 | 29 | $8.27M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Oragenics Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 56,364 | $81.0K | 0.00% | +40,936+265.3% | Added |
| Warberg Asset Management LLC | 50,028 | $72.0K | 0.02% | +50,028 | New |
| Virtu Financial LLC | 22,675 | $33.0K | 0.00% | +22,675 | New |
| BlackRock Inc. | 21,059 | $30.3K | 0.00% | −1,089−4.9% | Reduced |
| Geode Capital Management, LLC | 20,108 | $29.0K | 0.00% | +310+1.6% | Added |
| Susquehanna International Group, LLP | 10,301 | $14.8K | 0.00% | +10,301 | New |
| Tower Research Capital LLC (TRC) | 5,864 | $8.44K | 0.00% | +3,977+210.8% | Added |
| Bank of America Corp | 113 | $163 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 107 | $152 | 0.00% | +84+365.2% | Added |
| FMR LLC | 86 | $124 | 0.00% | −2,511−96.7% | Reduced |
| Wolff Wiese Magana LLC | 67 | $97 | 0.00% | +50+294.1% | Added |
| Wells Fargo & Company | 25 | $36 | 0.00% | +4+19.0% | Added |
| Chesapeake Asset Management LLC | 3 | $4 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Team Financial Group, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |